Marie-France Tschudin
Director/Board Member presso AXA
Patrimonio netto: 5 M $ in data 29/02/2024
Profilo
Marie-France Tschudin is on the board of AXA SA, IMD Scholarship Foundation and European Federation of Pharmaceutical Industries & Assoc.
In her past career she held the position of Chief Commercial Officer for Novartis AG and President at Advanced Accelerator Applications SA (a subsidiary of Novartis AG) and Vice President-Hematology & Oncology at Celgene International SARL.
Marie-France Tschudin received an undergraduate degree from Georgetown University and an MBA from International Institute for Management Development.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
NOVARTIS AG
0.00% | 31/12/2022 | 52 818 ( 0.00% ) | 5 M $ | 29/02/2024 |
Posizioni attive di Marie-France Tschudin
Società | Posizione | Inizio |
---|---|---|
AXA | Director/Board Member | 30/06/2020 |
IMD Scholarship Foundation | Director/Board Member | - |
European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - |
Precedenti posizioni note di Marie-France Tschudin
Società | Posizione | Fine |
---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 15/09/2023 |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | President | 01/06/2019 |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Corporate Officer/Principal | 01/01/2016 |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Director/Board Member | - |
Formazione di Marie-France Tschudin
Georgetown University | Undergraduate Degree |
International Institute for Management Development | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AXA | Finance |
NOVARTIS AG | Health Technology |
Aziende private | 5 |
---|---|
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
IMD Scholarship Foundation | |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
European Federation of Pharmaceutical Industries & Assoc |